$BYSI

BeyondSpring Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.165 ▲1.304%

Delayed Price

VOLUME

52,070

DAY RANGE

-

52 WEEK

1.13 - 33

Join Discuss about BYSI with like-minded investors

profile
@dros #droscrew
recently

Upgrades 12/2: $AEG $ALV $ARGX $BMA $CLBK $CUBE $EBAY $GGG $H $JKS $OKTA $PSA $SNOW $SSL . Downgrades 12/2: $BYSI $BZUN $CHH $EXPD $F $HIBB $ING $PINS $REAL $USX $WDH $WISH

52 Replies 10 👍 6 🔥

profile
@netxpert #marketassasins
recently

@everyone I am watching $BYSI $VBIV $ HCTI the first two FDA high probability approvals, the third one $HCTI post IPO bounce expected.

131 Replies 9 👍 10 🔥

BR
@Bruce1 #ivtrades
recently

shake fest in $BYSI...but I think greed will soon overcome the fat cats.

55 Replies 6 👍 13 🔥

BR
@Bruce1 #ivtrades
recently

good time to buy $BYSI !

99 Replies 6 👍 7 🔥

BR
@Bruce1 #ivtrades
recently

pretty convincing shakeout on $BYSI

76 Replies 15 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$bysi trend change

117 Replies 7 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$BYSI & $SPCE both going

125 Replies 13 👍 7 🔥

profile
@CarlosH-carvan #ivtrades
recently

damn watch this $BYSI for short selling

44 Replies 15 👍 8 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

$bysi had it swing short but covered pm like a chump

61 Replies 9 👍 10 🔥

profile
@TraderXx #StockTraders.NET
recently

$BYSI CEO on Benzinga Tv at 11:30 ET @Benzinga

73 Replies 8 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

watchlist for tomoroow: $WORX, $WHLR, $MVIS, $MOSY, $SCPS, $CEMI, $FLGC, $BYSI

133 Replies 15 👍 14 🔥

BJ
@Bjpaul13 #ivtrades
recently

you in $BYSI Carlos?

93 Replies 13 👍 7 🔥

profile
@CarlosH-carvan #ivtrades
recently

watch this $BYSI

66 Replies 6 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

i'm all covered $BYSI

52 Replies 8 👍 7 🔥

profile
@TraderXx #StockTraders.NET
recently

man $BYSI is sketch IMO, they will bid it up and than big red likely to follow

67 Replies 9 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

$BYSI halt up

59 Replies 11 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

I still have 1 share of $BYSI short lol

67 Replies 9 👍 15 🔥

profile
@Chano #StockTraders.NET
recently

everything halted! $WHLR $HOOD $BYSI

107 Replies 6 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

hopefully games in $BYSI to get another trade off

99 Replies 7 👍 12 🔥

profile
@viking #StockTraders.NET
recently

Upside: -CYCN +16% (announces Global Licensing agreement with Akebia Therapeutics for Praliciguat; eligible to receive up to $585M in milestone payments) -SFIX +12% (earnings, guidance) -REVG +10% (earnings, guidance) -CHS +9.9% (earnings, guidance) -EVOK +8.4% (announces FDA Orange Book Listing of U.S. Patent for Gimoti) -ASO +7.2% (earnings, guidance) -MCF +6.6% (to be acquired by Independence Energy in all stock transaction valued at ~$5.7B) -JILL +6.3% (earnings, guidance) -MRVL +5.6% (earnings, guidance) -BYSI +4.8% (announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data) -THO +4.1% (earnings) -STX +3.7% (raises guidance) -TSLA +2.9% (strong China May passenger vehicle sales) -INO +2.6% (expands partnership with Advaccine to conduct global Phase III efficacy trial of COVID-19 DNA vaccine candidate, INO-4800) -OTLK +2.3% (reports completion of patient dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial) -FTCI +1.4% (earnings, guidance; raising prices) -LUV +1.2% (guidance) Downside: -PLBY -10% (files to offer 4.0M shares) -COUP -8.9% (earnings, guidance; Tony Tiscornia promoted to CFO) -TIGR -7.6% (files to sell 6.5M ADS) -HSTO -7.5% (announces 6.0M share direct offering priced at $1.10/shr) -LESL -5.7% (to sell 24.5M shares for holders) -HQY -5.5% (earnings, guidance) -KDP -4.9% (files to sell 28M common share secondary offering on behalf of Mondelez International) -FTCI -4.7% (earnings, guidance; raising prices) -FSLY -1.7% (hearing Fastly edge CDN platform is having issues causing internet outages) -ETSY -1.3% (files proposed private offering of $1.0B of convertible senior notes) -WBA -1.3% (AMZN reportedly to offer discounted pharmacy services targeting uninsured and those paying cash)

121 Replies 10 👍 14 🔥

Key Metrics

Market Cap

44.77 M

Beta

1.51

Avg. Volume

261.28 K

Shares Outstanding

38.93 M

Yield

0%

Public Float

0

Next Earnings Date

2022-06-15

Next Dividend Date

Company Information

BeyondSpring is a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. BeyondSpring's lead asset, plinabulin, a first-in-class agent as an immune and stem cell modulator, is in a Phase 3 global clinical trial as a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC) and Phase 3 clinical programs in the prevention of CIN. The U.S. FDA granted Breakthrough Therapy designation to plinabulin for concurrent administration with myelosuppressive chemotherapeutic regimens in patients with non-myeloid malignancies for the prevention of chemotherapy-induced neutropenia (CIN). BeyondSpring has strong R&D capabilities with a robust pipeline in addition to plinabulin, including three immuno-oncology assets and a drug discovery platform using the protein degradation pathway, which is being developed in a subsidiary company, Seed Therapeutics, Inc. The Company also has a seasoned management team with many years of experience bringing drugs to the global market. BeyondSpring is headquartered in New York City.

Website:

HQ: ,

Related News